MAP2K7 and acute myeloid leukemia: In conclusion, our study demonstrates that SYK inhibition in AML favors cell differentiation in MEK-ERK1/2 dependent manner, targets LSCs through modulation of OXPHOS metabolism and increases their sensitivity to cytarabine.